AKTX vs ZLAB
Akari Therapeutics PLC · Zai Lab Ltd
Relative return (rebased to 100)
Key stats
| Metric | AKTX | ZLAB |
|---|---|---|
| Price | $10.70 | $26.08 |
| Market Cap | $1.67T | $29.27B |
| P/E | — | — |
| P/B | 89627.12 | 48.22 |
| P/S | 4530362.77 | 63.62 |
| ROE | -93.0% | -28.9% |
| Net Margin | -4702.1% | -38.1% |
| Gross Margin | — | 0.0% |
| Revenue Growth | -39.5% | 15.3% |
| Dividend Yield | — | — |
| EPS | -$0.00 | -$0.16 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.